Vaccination of risk groups in England using the 13 valent pneumococcal conjugate vaccine: economic analysis.

Rozenbaum, MH; van Hoek, AJ; Fleming, D; Trotter, CL; Miller, E; Edmunds, WJ; (2012) Vaccination of risk groups in England using the 13 valent pneumococcal conjugate vaccine: economic analysis. BMJ (Clinical research ed), 345. e6879. ISSN 0959-8138 DOI: https://doi.org/10.1136/bmj.e6879

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1136/bmj.e6879

Abstract

Share

Download

Filename: rozm004847.ww1_default.pdf

Licence: Creative Commons: Attribution-Noncommercial-No Derivative Works 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar